<Record>
<Term>Atreleuton</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Lipooxygenase Inhibitor</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Enzyme Inhibitor/Lipooxygenase Inhibitor/Atreleuton</ClassificationPath>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Enzyme Inhibitor</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Lipooxygenase Inhibitor</BroaderTerm>
<BroaderTerm>Atreleuton</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>((R)-3-(5-(p-Fluorobenzyl)-2-thienyl)-1-methyl-2-propynyl-1-hydroxyurea</Synonym>
<Synonym>A-85761</Synonym>
<Synonym>ABT-761</Synonym>
<Synonym>ATRELEUTON</Synonym>
<Synonym>Atreleuton</Synonym>
<Source>NCI Thesaurus</Source>
</Record>
